Antitumorigenic targets of cannabinoids – current status and implications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumorigenic targets of cannabinoids – current status and implications
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 10, Pages 1219-1235
Publisher
Informa UK Limited
Online
2016-04-13
DOI
10.1080/14728222.2016.1177512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
- (2016) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- The use of cannabinoids as anticancer agents
- (2016) Guillermo Velasco et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
- (2016) Katrin Winkler et al. Oncotarget
- French drug trial protocol fails to answer key questions
- (2016) Nigel Hawkes BMJ-British Medical Journal
- French drug trial protocol fails to answer key questions
- (2016) Nigel Hawkes BMJ-British Medical Journal
- Delta9-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature
- (2015) CJ Fowler CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms
- (2015) Bani Mukhopadhyay et al. HEPATOLOGY
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors
- (2015) Valeria Gasperi et al. LIFE SCIENCES
- Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells
- (2015) Elena Ciaglia et al. Oncotarget
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
- (2015) Janani Ravi et al. Oncotarget
- Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
- (2014) Enrico Michelino Messalli et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
- (2014) Maria Haustein et al. BIOCHEMICAL PHARMACOLOGY
- Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
- (2014) Robert Ramer et al. BIOCHEMICAL PHARMACOLOGY
- Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
- (2014) Ryuichi Murase et al. BRITISH JOURNAL OF PHARMACOLOGY
- Heteromerization of GPR55 and cannabinoid CB2receptors modulates signalling
- (2014) N A Balenga et al. BRITISH JOURNAL OF PHARMACOLOGY
- Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
- (2014) Francesca Borrelli et al. CARCINOGENESIS
- Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
- (2014) Seok-Woo Park et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
- (2014) Estefanía Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Combination of Cannabidiol and 9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
- (2014) K. A. Scott et al. MOLECULAR CANCER THERAPEUTICS
- Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray
- (2014) Jenny Häggström et al. PROSTATE
- Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK
- (2013) Ellen Schmuhl et al. BIOCHEMICAL PHARMACOLOGY
- The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action
- (2013) María Salazar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
- (2013) Thomas J.W. Klein Nulent et al. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
- Role of Cannabinoid and Vanilloid Receptors in Invasion of Human Breast Carcinoma Cells
- (2013) N. Farsandaj et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme
- (2013) Dolores Hernán Pérez de la Ossa et al. PLoS One
- The endocannabinoid signaling system in cancer
- (2013) Simona Pisanti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
- (2012) Laurie Hamtiaux et al. BMC CANCER
- Cannabidiol inhibits angiogenesis by multiple mechanisms
- (2012) M Solinas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
- (2012) L. Soroceanu et al. CANCER RESEARCH
- Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
- (2012) Chiara Laezza et al. EUROPEAN JOURNAL OF CANCER
- Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
- (2012) I. A. Khasabova et al. JOURNAL OF NEUROSCIENCE
- COX-2 and PPAR- Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
- (2012) R. Ramer et al. MOLECULAR CANCER THERAPEUTICS
- The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas
- (2012) E Pérez-Gómez et al. ONCOGENE
- Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells
- (2012) Nazila Pourkhalili et al. TOXICOLOGY MECHANISMS AND METHODS
- Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
- (2011) Giuseppina Cantarella et al. BIOCHEMICAL PHARMACOLOGY
- Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis
- (2011) S. Pisanti et al. BLOOD
- Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer
- (2011) Lin Ye et al. CANCER LETTERS
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
- (2011) D Vara et al. CELL DEATH AND DIFFERENTIATION
- Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate Cancer
- (2011) Daniel K. Nomura et al. CHEMISTRY & BIOLOGY
- Update on the endocannabinoid system as an anticancer target
- (2011) Anna Maria Malfitano et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
- (2011) Robert Ramer et al. FASEB JOURNAL
- Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth
- (2011) Maria C. Proto et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
- (2011) A. Shrivastava et al. MOLECULAR CANCER THERAPEUTICS
- Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
- (2011) Laurie Hamtiaux et al. PLoS One
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells
- (2010) Mohanraj Rajesh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator
- (2010) X Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Dual Effects of Δ9-Tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration
- (2010) Surang Leelawat et al. CANCER INVESTIGATION
- Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
- (2010) A. Preet et al. Cancer Prevention Research
- Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis
- (2010) Dinesh Thapa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma
- (2010) Gorka Larrinaga et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
- (2010) María M Caffarel et al. Molecular Cancer
- The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
- (2010) C Andradas et al. ONCOGENE
- The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
- (2010) R Piñeiro et al. ONCOGENE
- The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
- (2010) Eiron Cudaback et al. PLoS One
- Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4
- (2010) Lina Thors et al. PLoS One
- Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
- (2009) Robert Ramer et al. BIOCHEMICAL PHARMACOLOGY
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
- (2009) Daniel K. Nomura et al. CELL
- Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
- (2009) María Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus
- (2009) J. E. Schlosburg et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antitumorigenic Effects of Cannabinoids beyond Apoptosis
- (2009) N. Freimuth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma
- (2009) S. Oesch et al. MOLECULAR CANCER THERAPEUTICS
- Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
- (2009) Z. Qamri et al. MOLECULAR CANCER THERAPEUTICS
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
- (2009) J. Z. Long et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
- (2008) G-One Ahn et al. CANCER CELL
- Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
- (2008) D. Wang et al. CANCER RESEARCH
- Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
- (2008) C. Blazquez et al. CANCER RESEARCH
- A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
- (2008) Sui Chu Chung et al. EUROPEAN JOURNAL OF CANCER
- Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)
- (2008) Michelle L. Holland et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The GPR55 ligand l-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
- (2008) Christopher M. Henstridge et al. FASEB JOURNAL
- Expression and function of fatty acid amide hydrolase in prostate cancer
- (2008) Michael P. Endsley et al. INTERNATIONAL JOURNAL OF CANCER
- Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
- (2008) Natasha L. Grimsey et al. JOURNAL OF NEUROSCIENCE METHODS
- HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α
- (2008) Zoltan Arany et al. NATURE
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
- (2008) W. G. Stetler-Stevenson Science Signaling
- The endocannabinoid system in cancer—Potential therapeutic target?
- (2008) Jenny Flygare et al. SEMINARS IN CANCER BIOLOGY
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
- (2007) D G Johns et al. BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids in pancreatic cancer: Correlation with survival and pain
- (2007) Christoph W. Michalski et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
- (2007) Robert Ramer et al. JNCI-Journal of the National Cancer Institute
- Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
- (2007) Cristina Blázquez et al. NEUROPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started